Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Kaustubh Tambwekar"'
Development of age appropriate, patient friendly and flexible dosage forms of an anticancer compound
Publikováno v:
International Journal of Pharmaceutics. 511:1140-1141
Publikováno v:
Journal of Pharmaceutical and Biomedical Analysis. 32:441-450
A reverse phase HPLC method using C18 column has been developed for the quantitative estimation of nicotine in the bulk material and formulations (extended release and immediate release dosage forms). The method is specific to nicotine (RT approximat
Publikováno v:
International Journal of Pharmaceutics. 255:13-32
The concept of controlled drug delivery has been traditionally used to obtain specific release rates or spatial targeting of active ingredients. The phenomenon of bioadhesion, introduced by Park and Robinson [Park, K., Robinson, J.R., 1984. Bioadhesi
Autor:
Gunjan Kohli, Lourens J.D. Zaneveld, Alka Garg, Raghupathi Kandarapu, Kaustubh Tambwekar, Kavita Vermani, Sanjay Garg, Donald P. Waller
Publikováno v:
International Journal of Pharmaceutical Medicine. 16:141-152
The vagina is a potential site for the local and systemic delivery of drugs. Presently, significant attention is given to the development of vaginal formulations (‘microbicides’) that prevent sexual acquisition of acquired immunodeficiency syndro
Autor:
Raghupathi Kandarapu, Alka Garg, Donald P. Waller, Sanjay Garg, Kaustubh Tambwekar, Kavita Vermani, Lourens J.D. Zaneveld
Publikováno v:
AIDS patient care and STDs. 17(8)
In recent years, AIDS and sexually transmitted diseases (STDs) have become a burgeoning problem and are spreading at an alarming rate. Microbicides are being developed as a new therapeutic category for prevention of transmission of sexually transmitt
Autor:
Lourens J.D. Zaneveld, Alka Garg, Raghupathi Kandarapu, Kaustubh Tambwekar, Donald P. Waller, Sanjay Garg, Kavita Vermani
Publikováno v:
AIDS patient care and STDs. 17(1)
Microbicides, the compounds and formulations that can prevent transmission of sexually transmitted diseases (STDs)/HIV are being pursued actively as a promising AIDS intervention. The drug development chain for a topical microbicide differs significa